EGFR and breast neoplasm: Yet, additional mechanisms complicating the scenario have been described, since the inhibitory interaction of Cav-1 with the epidermal growth factor receptor can be hindered by the formation of a galectin-glycoprotein lattice, thereby resulting in sustained receptorial activity, as observed in breast tumor cells [60], [61].